Published in J Rheumatol on July 01, 1989
Outcome studies, mortality versus quality of life. J Rheumatol (1989) 1.39
Evaluation of lateral instability of the atlanto-axial joint in rheumatoid arthritis using dynamic open-mouth view radiographs. Clin Rheumatol (2007) 0.75
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med (1995) 5.18
Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol (2001) 3.87
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 3.53
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum (1994) 3.15
Sociocultural issues in clinical research. Arthritis Rheum (2001) 2.71
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (1990) 2.59
Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum (1993) 2.49
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 2.24
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum (1997) 1.92
Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis Rheum (1988) 1.91
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol (1998) 1.88
Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum (1985) 1.88
Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. J Rheumatol (1999) 1.87
Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope) Ann Intern Med (1995) 1.86
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.85
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus (2002) 1.85
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum (1996) 1.77
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
A new promising treatment in systemic sclerosis: 5-fluorouracil. Ann Rheum Dis (1987) 1.62
Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin Arthritis Rheum (1982) 1.62
Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum (1992) 1.62
Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum (1990) 1.59
Small joint involvement: a systematic roentgenographic study in rheumatoid arthritis. Ann Rheum Dis (1986) 1.54
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun (2008) 1.53
Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum (1997) 1.51
Methotrexate and sulfasalazine combination therapy: is it worth the risk? Arthritis Rheum (1993) 1.47
Rheumatoid synovial fibroblast adhesion to human articular cartilage. Enhancement by neutrophil proteases. Arthritis Rheum (1995) 1.42
Intraarticular corticosteroid injections: should we rest the joints? Arthritis Care Res (1989) 1.41
Silicone gel and hypersensitivity. Plast Reconstr Surg (1996) 1.39
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37
Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum (1989) 1.36
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.35
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum (1998) 1.35
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum (1995) 1.28
Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. Arthritis Rheum (1999) 1.27
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis Rheum (1982) 1.22
Laminin cleavage by activated human neutrophils yields proteolytic fragments with selective migratory properties. J Leukoc Biol (1993) 1.21
Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis (2006) 1.20
Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) (2003) 1.19
Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med (1980) 1.19
Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol (2004) 1.17
International consensus for a definition of disease flare in lupus. Lupus (2010) 1.16
Genetic associations of LYN with systemic lupus erythematosus. Genes Immun (2009) 1.15
Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum (1993) 1.15
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis (2010) 1.12
Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity. Clin Exp Immunol (1978) 1.12
Coping strategies predict disability in patients with primary fibromyalgia. Pain (1996) 1.12
Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage. Arthritis Care Res (1998) 1.11
A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun (2012) 1.08
Toxicity of methotrexate in rheumatoid arthritis. J Rheumatol (1987) 1.08
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun (2011) 1.07
Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. Rheumatology (Oxford) (2008) 1.07
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) (2012) 1.06
The early diagnosis of transient osteoporosis by magnetic resonance imaging. A case report. J Bone Joint Surg Am (1992) 1.06
Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol (1991) 1.06
Coexistence of rheumatoid arthritis and sarcoidosis: difficulties encountered in the differential diagnosis of common manifestations. J Rheumatol (1984) 1.05
Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus (2012) 1.05
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology (Oxford) (2005) 1.03
Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am J Pathol (1990) 1.03
Chronic tenosynovial hand infection from Mycobacterium terrae. Arthritis Rheum (1979) 1.02
Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis (2004) 1.01
Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods. Arthritis Rheum (1979) 1.01
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum (2008) 1.01
Predicting individual differences in pain and functional impairment among patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.00
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) (2006) 1.00
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis (2008) 0.99
Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin Exp Rheumatol (1993) 0.99
Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum (1988) 0.99
Involvement of the cervical spine in rheumatoid arthritis. Arthritis Rheum (1989) 0.98
Degradation of human articular cartilage by neutrophils in synovial fluid. Arthritis Rheum (1993) 0.98
DR antigen distribution in Blacks with rheumatoid arthritis. J Rheumatol (1983) 0.97
Psychosocial and health status variables independently predict health care seeking in fibromyalgia. Arthritis Rheum (2001) 0.97
Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus (2003) 0.97
Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]. Clin Exp Rheumatol (2008) 0.97
A controlled study of ANA+ RF- arthritis. Arthritis Rheum (1979) 0.96
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun (2009) 0.96
Differential patterns of in vitro IgM rheumatoid factor synthesis in seronegative and seropositive rheumatoid arthritis. Arthritis Rheum (1982) 0.96
Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and others. Arthritis Rheum (2000) 0.96
Atlantoaxial (C1-C2) facet joint osteoarthritis: a distinctive clinical syndrome. Arthritis Rheum (1987) 0.95
Prosthetic joint infections. A role for prophylaxis. Arthritis Rheum (1991) 0.95
Nonreducible rotational head tilt and lateral mass collapse. A prospective study of frequency, radiographic findings, and clinical features in patients with rheumatoid arthritis. Arthritis Rheum (1982) 0.95
Thrombotic thrombocytopenic purpura in systemic sclerosis. J Rheumatol (1989) 0.95
Disease and psychosocial factors related to physical functioning in rheumatoid arthritis. J Rheumatol (1991) 0.94
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol (1997) 0.94
Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study. J Rheumatol (1987) 0.94
Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus (2007) 0.94
Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. Arthritis Care Res (1999) 0.93
Rheumatoid arthritis in American blacks: a clinical and radiological study. J Rheumatol (1989) 0.93